However, AAV-BMPER injection led to the normalization of hyperinsulinemia and hyperglycemia (Fig. 6f, g, Supplementary Fig. 12c, d), improved glucose clearance and insulin sensitivity, and decreased TG and DAG contents in db/db mice (Fig. 6h, Supplementary Table 2). The gene discussed is INS; the disease is Hyperglycemia.